Incorporated in 2003, Infinium Pharmachem Limited manufactures & supplies Iodine Derivatives, APIs, and Iodination reaction-based bulk drugs.
The company offers R & D services and commercial scale manufacturing and packaging for Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals & other chemical industries.
Infinium Pharmachem's manufacturing plant is located in Gujarat - INDIA, which spans across 4100 Sq. Mtr. Plot area. The facility is FDA certified & GMP compliant with capabilities of producing complex Iodine Derivatives.
The company serves to over 15+ countries across the globe and has over 200+ Iodine Derivatives and 7+ APIs.
Infinium Pharmachem IPO Details
Infinium Pharmachem IPO is a Fixed Price Issue. The IPO total issue size is Rs 25.26 Cr. The Infinium Pharmachem IPO price is ₹135 per share. The IPO will list on NSE SME.
Infinium Pharmachem IPO Reservation
Infinium Pharmachem IPO a total of 1,969,000 shares are offered. RII: 937,500 (47.61%), NII: 937,500 (47.61%).
Infinium Pharmachem IPO Timetable (Tentative)
Infinium Pharmachem IPO opens on Mar 31, 2023, and closes on Apr 5, 2023.
Infinium Pharmachem IPO Lot Size
The minimum lot size of this Infinium Pharmachem IPO is 1000 shares required is ₹135,000.
Infinium Pharmachem IPO Promoter Holding
Mr. Sanjaykumar Viththalbhai Patel, Mr. Pravin Bhadabhai Madhani, and Mr. Mitesh Lavjibhai Chikhaliya are the company promoters.
Company Financials
Key Performance Indicator
Infinium Pharmachem IPO Market Cap is Rs 93.93 Cr and P/E (x) is 7.83.
Post a Comment